News

Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports

A study of nursing home residents found the monoclonal antibody treatment bamlanivimab cut the risk of COVID-19 by up to 80%, maker Eli Lilly announced.